Which has the lower trailing P/E, ABT or ISRG?

ABT has the lower trailing P/E: ABT trades at 36.79 and ISRG at 45.25. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or ISRG?

Over the past five years, ISRG grew revenue faster — ABT at a 2.98% CAGR versus ISRG at 16.41%.

Does ABT or ISRG pay a bigger dividend?

ABT pays a dividend (2.17% yield), while ISRG has no payments in the available dividend history.

Is ABT or ISRG more profitable?

ISRG runs the higher net margin — ABT at 11.65% versus ISRG at 28.45%.

How have ABT and ISRG total returns compared?

Over the past 10 years, ABT delivered 12.06% and ISRG delivered 17.94% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Intuitive Surgical, Inc. (ISRG)

A side-by-side comparison of Abbott Laboratories and Intuitive Surgical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 19, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$198.06B

$114.46HealthcareDelayed quote: Aug 19, 2026, 3:59 PM EDT

ISRG

Intuitive Surgical, Inc.

$140.51B

$397.72HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — ABT vs ISRG

growth of $100 · dividends reinvested · last 10y

ABT +219.9% (+12.3%/yr)ISRG +424.1% (+18.0%/yr)ISRG compounded faster over this window

ABT ISRG

ABT vs ISRG: by the numbers

•ABT is the larger company ($198.06B vs $140.51B market cap).
•ABT trades at the lower trailing earnings multiple (36.79 vs 45.25 P/E), one valuation lens rather than an overall verdict.
•ISRG converts more revenue to profit (28.45% vs 11.65% net margin).
•ISRG grew revenue faster over the past five years (16.41% vs 2.98% CAGR).
•ABT pays a dividend (2.17% yield), while ISRG has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ABT	ISRG
P/E ratio	36.79	45.25
Forward P/E	20.75	36.83
P/S ratio	4.28	12.92
P/B ratio	3.90	7.85
EV / EBITDA	20.84	33.04
FCF yield	4.37%	2.26%

Profitability

Metric	ABT	ISRG
Gross margin	56.80%	66.68%
Operating margin	17.03%	31.28%
Net margin	11.65%	28.45%
ROE	10.61%	17.28%
ROIC	6.07%	15.11%

Dividends

Metric	ABT	ISRG
Dividend yield	2.17%	N/A
Payout ratio	66.31%	N/A

Growth (annualized)

Metric	ABT	ISRG
Revenue CAGR (5Y)	2.98%	16.41%
EPS CAGR (5Y)	8.22%	21.51%
FCF CAGR (5Y)	0.18%	14.17%
Total return CAGR (5Y)	0.07%	2.48%

Frequently asked

Which has the lower trailing P/E, ABT or ISRG?: ABT has the lower trailing P/E: ABT trades at 36.79 and ISRG at 45.25. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or ISRG?: Over the past five years, ISRG grew revenue faster — ABT at a 2.98% CAGR versus ISRG at 16.41%.
Does ABT or ISRG pay a bigger dividend?: ABT pays a dividend (2.17% yield), while ISRG has no payments in the available dividend history.
Is ABT or ISRG more profitable?: ISRG runs the higher net margin — ABT at 11.65% versus ISRG at 28.45%.
How have ABT and ISRG total returns compared?: Over the past 10 years, ABT delivered 12.06% and ISRG delivered 17.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full ISRG analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Intuitive Surgical P/E ratio Abbott Laboratories dividend yield Abbott Laboratories ROE Intuitive Surgical ROE Abbott Laboratories operating margin Intuitive Surgical operating margin Abbott Laboratories revenue growth Intuitive Surgical revenue growth Abbott Laboratories free cash flow Intuitive Surgical free cash flow

Abbott Laboratories & Intuitive Surgical appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 19, 2026.